1981
DOI: 10.1016/0006-2944(81)90013-2
|View full text |Cite
|
Sign up to set email alerts
|

Levels of adenosine deaminase, AMP deaminase, and adenylate kinase in cultured human lymphoblast lines: Exquisite sensitivity of AMP deaminase to adenosine deaminase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

1982
1982
2000
2000

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(6 citation statements)
references
References 24 publications
1
5
0
Order By: Relevance
“…The B and null cell lines studied, which derive from normal cells, are considered as mature cells with low terminal deoxynucleotidyltransferase (TdT) activity ( 12), while T-ALL lymphoblasts display high TdT levels which reflect early stages of maturation. Our results agree with those of Fishbein (9) and suggest that AMP-DA, like ecto-5" and unlike ADA, increases during cell differentiation (Table 11).…”
Section: 9supporting
confidence: 95%
See 3 more Smart Citations
“…The B and null cell lines studied, which derive from normal cells, are considered as mature cells with low terminal deoxynucleotidyltransferase (TdT) activity ( 12), while T-ALL lymphoblasts display high TdT levels which reflect early stages of maturation. Our results agree with those of Fishbein (9) and suggest that AMP-DA, like ecto-5" and unlike ADA, increases during cell differentiation (Table 11).…”
Section: 9supporting
confidence: 95%
“…The enzyme form(s) present in immature thymocytes poorly deaminates dAMP and is highly inhibited by deoxycoformycin, unlike that present in mature T cells. Such a differenze in deoxycoformycin sensitivity has been reported for the enzymes expressed in T-ALL and B or null lymphoblastoid cell lines (9).…”
Section: Non-t Non-b Chronic Myelocytic Leukemiamentioning
confidence: 96%
See 2 more Smart Citations
“…The effects of the nucleoside transport inhibitors DPR (1 n M ‐30 μ M ) and NBMPR (1 n M ‐30 μ M ) on 3 H‐purine release were tested. In addition, the contribution of specific enzymes to the metabolism and release of 3 H‐purines was examined using 1 μ M EHNA to inhibit adenosine deaminase, 100 μ M EHNA to inhibit both adenosine deaminase and AMP deaminase (Fishbein et al, 1981), and 10 μ M BCX‐34 to inhibit purine nucleoside phosphorylase (PNP) (Jurkowitz, et al, 1998). In some experiments cells were treated with IAA and NaCN and then washed and returned to Na + buffer to mimic a return to normoxic conditions.…”
Section: Rt‐pcr Analysismentioning
confidence: 99%